wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38371450-7F081F0E-EAC8-4569-9057-6DE5ACE2147C
Q38371450-7F081F0E-EAC8-4569-9057-6DE5ACE2147C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371450-7F081F0E-EAC8-4569-9057-6DE5ACE2147C
Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study.
P2860
Q38371450-7F081F0E-EAC8-4569-9057-6DE5ACE2147C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371450-7F081F0E-EAC8-4569-9057-6DE5ACE2147C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b41e46346cbab92c4cf68afdbeed9b169390a2d
P2860
Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial.